期刊文献+

单核苷酸多态性的分子标记及其相关研究 被引量:1

原文传递
导出
作者 刘欣跃
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2009年第6期717-720,共4页 Chinese Journal of Nosocomiology
基金 国家自然科学基金资助项目(30772068) 甘肃省自然科学基金资助项目(3ZS061-A25-084)
  • 相关文献

参考文献15

  • 1Kandil E, Burack J, Sawas A, et al. B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock[J]. Arch Surg, 2008,143 (3):242- 246.
  • 2Bluth M, Lin YY, Zhang H, et al. Use of gene expression profiles in cells of peripheral blood to identify new molecular markers of acute pancreatitis[J]. Arch Surg, 2008, 143 (3) : 227-234.
  • 3de Wit MC, Lequin MH, de Coo IF, et al. Cortical brain malformations., effect of clinical, neuroradiological, and modern genetic classification[J]. Arch Neurol, 2008,65 (3) : 358- 566.
  • 4Feero WG, Guttmacher AE, Collins FS. The genome gets personal-almost[J]. JAMA,2008,299(11) :1351-1352.
  • 5International Human Genome Sequencing Consortium. Finishing the euehromatie sequence of the human genome[J]. Nature, 2004,431 : 931-945.
  • 6Hinds DA, Stuve LL, Nilsen G, et al. Whole-genome patterns of common DNA variation in three human populations [J]. Science, 2005,307,1072-107.9.
  • 7Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson Syndrome[J]. Nature, 2004,428 (6982) :486.
  • 8Bertino JR, Banerjee D, Mishra PJ. Pharmacogenomics of microRNA: a miRSNP towards individualized therapy[J ]. Pharmacogenomics,2007,8(12) : 1625-1627.
  • 9Man CB, Kwan P, Baum L, et al. Association between HLA-B 1502 allele and antiepileptic drug induced cutaneous reactions in Han Chinese[J]. Epilepsia,2007,48(5):1015 -1018.
  • 10Agrawal S, Khan F. Human genetic variation and personal ized medicine[J]. Ind J Physiol Pharmaeol,2007,51(1) :7 -28.

二级参考文献10

共引文献30

同被引文献29

  • 1Lakhman SS, Ma Q, Morse GD,et al. Pharmacogenomics of C YP3A: considerations for HIV treatment [ J 1. Pharmocogenomics, 2009, 10 (8) :1323-1339.
  • 2Hesselink DA, van Schaik RHN, van der Heiden IP, et al. Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and phar- macokinetics of the calcineurin inhibitors cyclosporine and tacrolimus [ J ]. Clin Pharmacol Ther,2003,74 ( 3 ) :245-254.
  • 3Keiko M, Tetsuya S, Yoshiki T,et al. Identification of a novel poly- morphic enhancer of the human CYP3A4 gene [ J ]. Mol Pharmacol, 2004,65(2) :326-334.
  • 4Sarah C Sim. CYP3A4 allele nomenelature[EB/OL]. (2013-07-04) [2014-03-24]. http://www, cypalleles, ki. se/eyp3a4, htm.
  • 5Zhou Q, Yu x, Shu C, et al. Analysis of CYP3A4 genetic polymor- phisms in Han Chinese[J]. J Hum Genet,2011,56(6) :415-422.
  • 6Britt DrSgemller, Marieth Plummer, Lundi Korkie,et al. Character- ization of the genetic variation present in CYP3A4 in three South Afri- can populations [ J ]. Front Genet,2013,4 : 17.
  • 7Zaied C, Abid S, Mtiraoui N,et al. Cytochrome P450 (CYP3A4 * 18) and glutathione-S-transferase ( GSTP1 ) polymorphisms in a healthy Tunisian population [ J] . Genet Test Mol Biomarkers,2012, 16(10) :1184-1187.
  • 8Zuo J, Xia D, Jia L,et al. Genetic polymorphisms of drug-metaboliz- ing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations [ J ]. Pharmaz- ie ,2012,67 (7) :639-644.
  • 9Yousef M, Bulatova N R, Newman W,et al. Allele and genotype frequencies of the polymorphic cytochrome 17450 genes ( CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19 in the Jordanian popu- lation[ J]. Mol Biol Rep ,2012 ,39 (10) :9423-9433.
  • 10Saytito61u M, Yildiz I, Hatirnaz O, et al. Common cytochrome p4503A (CYP3A4 and CYP3A5) and thiopurine S-methyl transfer- ase (TPMT) polymorphisms in Turkish population [ J ]. Turk J Med Sci,2006,36 : 11-15.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部